Unity Biotechnology, Inc. Quarterly Interest Expense in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Unity Biotechnology, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q1 2024.
  • Unity Biotechnology, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Unity Biotechnology, Inc. Interest Expense for the twelve months ending March 31, 2024 was $1.45M, a 61.4% decline year-over-year.
  • Unity Biotechnology, Inc. annual Interest Expense for 2023 was $2.45M, a 31.1% decline from 2022.
  • Unity Biotechnology, Inc. annual Interest Expense for 2022 was $3.56M, a 12% increase from 2021.
  • Unity Biotechnology, Inc. annual Interest Expense for 2021 was $3.18M, a 146% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.45M $0 -$1M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.45M $1K -$989K -99.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 $3.44M $566K -$300K -34.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $3.74M $883K -$11K -1.23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $3.75M $1M +$194K +24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $3.56M $990K +$164K +19.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 $3.39M $866K +$74K +9.34% Jul 1, 2022 Sep 30, 2022 10-K 2024-04-15
Q2 2022 $3.32M $894K +$110K +14% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.21M $808K +$33K +4.26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.18M $826K +$33K +4.16% Oct 1, 2021 Dec 31, 2021 10-K 2024-04-15
Q3 2021 $3.14M $792K +$293K +58.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.85M $784K +$784K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.07M $775K +$775K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.29M $793K Oct 1, 2020 Dec 31, 2020 10-K 2023-03-15
Q3 2020 $499K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.